AI filing briefs · archive

8-K filings in May 2025, explained

1,062 material Form 8-K filings that 827 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2 of 1,062 briefs match

newest first · times in ET
ULTAUlta Beauty, Inc. May 29, 4:07 PM ET

Ulta Beauty Q1 sales rise 4.5% to $2.8 billion; raises fiscal 2025 EPS outlook

Positive guidance Written later 2.02

Ulta Beauty reported first-quarter fiscal 2025 results for the period ended May 3, 2025, with net sales up 4.5% to $2.8 billion and diluted earnings per share of $6.70, versus $6.47 a year earlier. Net income fell to $305.1 million from $313.1 million, and operating margin declined to 14.1% from 14.7%. The company raised its fiscal 2025 diluted EPS outlook to $22.65 to $23.20 from $22.50 to $22.90.

  • Net sales rose 4.5% to $2.8 billion; comparable sales increased 2.9%, driven by a 2.3% rise in average ticket and a 0.6% rise in transactions.
  • Diluted EPS was $6.70 versus $6.47, while net income declined to $305.1 million from $313.1 million and the effective tax rate rose to 24.6% from 23.2%.
  • Fiscal 2025 outlook: diluted EPS raised to $22.65 to $23.20 from $22.50 to $22.90; net sales raised to $11.5 billion to $11.7 billion; comparable sales raised to 0% to 1.5%.
  • Share repurchases of $358.7 million in the quarter; $2.3 billion remained under the $3.0 billion program as of May 3, 2025.
Read the filing on SEC.gov ↗
BBYBEST BUY CO INC May 29, 7:00 AM ET

Best Buy cuts FY26 adjusted EPS guidance as Q1 earnings and sales decline

Negative guidance Written later 2.02

Best Buy reported first-quarter fiscal 2026 revenue of $8.77 billion, down from $8.85 billion a year earlier, with comparable sales down 0.7%. Diluted EPS fell to $0.95 from $1.13, and adjusted diluted EPS fell to $1.15 from $1.20, after $109 million of restructuring charges tied to its Best Buy Health business. The company also lowered its full-year fiscal 2026 adjusted diluted EPS guidance to $6.15 to $6.30 from $6.20 to $6.60, citing tariffs, which weighs on shareholder returns.

  • Q1 revenue was $8.77 billion versus $8.85 billion; enterprise comparable sales fell 0.7%
  • Diluted EPS was $0.95 versus $1.13; adjusted diluted EPS was $1.15 versus $1.20
  • FY26 revenue guidance cut to $41.1 billion to $41.9 billion from $41.4 billion to $42.2 billion
  • Board declared a quarterly dividend of $0.95 per share, payable July 10, 2025
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.